Anzeige
Meldung des Tages: Der nächste Gold-Hebel? 200 Meter Treffer, volle Kassen – warum diese Aktie jetzt auffällt

Xencor Aktie News

Aktie
WKN:  A1W96L ISIN:  US98401F1057 US-Symbol:  XNCR Branche:  Biotechnologie Land:  USA
10,70 €
+0,00 €
0,00%
13:02:03 Uhr
Depot/Watchlist
Marktkapitalisierung *
910,99 Mio. €
Streubesitz
-
KGV
-7,23
Index-Zuordnung
-

Xencor News

08.01.26 - Businesswire
Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones
Xencor, Inc. (NASDAQ:XNCR), a clinical-​stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today ...
09.12.25 - Businesswire
Xencor Announces Extension of U.S. Patent Term on Certain Xtend™ Antibodies
Xencor, Inc. (NASDAQ:XNCR), a clinical-​stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today ...
10.11.25 - Businesswire
Xencor to Participate at Upcoming Investor Conferences
Xencor, Inc. (NASDAQ:XNCR), a clinical-​stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today ...
05.11.25 - Businesswire
Xencor Reports Third Quarter 2025 Financial Results
Xencor, Inc. (NASDAQ:XNCR), a clinical-​stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported ...
24.10.25 - Businesswire
Xencor Presents Initial Data for XmAb819, a First-in-class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Clear Cell Renal Cell Carcinoma
Xencor, Inc. (NASDAQ:XNCR), a clinical-​stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today ...
17.10.25 - PR Newswire
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation PR Newswire
17.10.25 - PR Newswire
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation PR Newswire

Newssuche

Videos

newspaper
11:20 Uhr +1,80%
Technical Trading: Gold Zukauf
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »